This study used inhaled endotoxin ( LPS ) challenge as a model of innate immune activation to ( 1 ) assess the safety of the IL-1 receptor antagonist anakinra in conjunction with inhaled LPS and ( 2 ) to test the hypothesis that IL-1 blockade will suppress the acute neutrophil response to challenge with inhaled LPS .